STUDY OF ANTIATHEROSCLEROTIC AND ENDOTHELIOPROTECTIVE ACTIVITY OF PEPTIDE AGONISTS OF EPOR/CD131 HETERORECEPTOR

STUDY OF ANTIATHEROSCLEROTIC AND ENDOTHELIOPROTECTIVE ACTIVITY OF PEPTIDE AGONISTS OF EPOR/CD131 HETERORECEPTOR

Introduction. The drugs affecting a mitochondrial dysfunction, oxidative stresses, apoptosis and inflammation of the vascular wall, have a high potential for the prevention and treatment of atherosclerotic lesions. In this regard, the use of EPOR/CD131 heteroreceptor agonists which have a similar sp...

ver descrição completa

Detalhes bibliográficos
Main Authors: Olesya A. Puchenkova, Sergey V. Nadezhdin, Vladislav O. Soldatov, Maxim A. Zhuchenko, Diana S. Korshunova, Marina V. Kubekina, Evgeny N. Korshunov, Liliya V. Korokina, Polina A. Golubinskaya, Aleksandr L. Kulikov, Vladimir V. Gureev, Vladimir M. Pokrovskiy, Evgeniy A. Patrakhanov, Petr R. Lebedev, Tatyana A. Denisyuk, Veronika S. Belyaeva, Evgeniya A. Movchan, Elizaveta I. Lepetukha, Mikhail V. Pokrovskiy
Formato: Artigo
Idioma:Russian
Publicado em: Volgograd State Medical University, Pyatigorsk Medical and Pharmaceutical Institute 2020-10-01
Colecção:Фармация и фармакология (Пятигорск)
Assuntos:
atherosclerosis
erythropoietin derivatives
mitochondrial dysfunction
oxidative stress
Acesso em linha:https://www.pharmpharm.ru/jour/article/view/687

Internet

https://www.pharmpharm.ru/jour/article/view/687

Registos relacionados